Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.

Dobrzycka, Bozena; Mackowiak-Matejczyk, Beata; Terlikowska, Katarzyna Maria; Kinalski, Maciej; Terlikowski, Slawomir Jerzy

Dobrzycka, Bozena; Mackowiak-Matejczyk, Beata; Terlikowska, Katarzyna Maria; Kinalski, Maciej; Terlikowski, Slawomir Jerzy.

Afiliação

Dobrzycka B; Department of Obstetrics, Gynecology and Maternity Care, Medical University of Bialystok, Bialystok, Poland.
Mackowiak-Matejczyk B; Department of Gynecologic Oncology, Bialystok Oncology Center, Bialystok, Poland.
Terlikowska KM; Department of Food Science and Technology, Medical University of Bialystok, Bialystok, Poland.
Kinalski M; Department of Gynecology and Obstetrics, Provincial Hospital in Bialystok, Bialystok, Poland.
Terlikowski SJ; Department of Obstetrics, Gynecology and Maternity Care, Medical University of Bialystok, Bialystok, Poland. Electronic address: sterlikowski@gmail.com.

Adv Med Sci ; 61(1): 23-7, 2016 Mar.

Article em En | MEDLINE | ID: mdl-26344910

Assuntos

Carcinoma Endometrioide/diagnóstico; Carcinoma Endometrioide/cirurgia; Neoplasias do Endométrio/diagnóstico; Neoplasias do Endométrio/cirurgia; Excisão de Linfonodo; Proteínas/metabolismo; Área Sob a Curva; Biomarcadores Tumorais/sangue; Antígeno Ca-125/sangue; Carcinoma Endometrioide/sangue; Carcinoma Endometrioide/patologia; Neoplasias do Endométrio/sangue; Neoplasias do Endométrio/patologia; Feminino; Humanos; Gradação de Tumores; Estadiamento de Neoplasias; Curva ROC; Proteína 2 do Domínio Central WAP de Quatro Dissulfetos

Palavras-chave

CA125; Endometrial cancer; HE4; Lymphadenectomy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google